Fingerprint
Dive into the research topics of 'Phase II trial of imatinib (Gleevec®) in patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Jacqueline Vuky, Christina Isacson, Mehran Fotoohi, Jason Dela Cruz, Henry Otero, Vincent Picozzi, Thomas Malpass, David Aboulafia, Andrew Jacobs
Research output: Contribution to journal › Article › peer-review